| 000 | 01653naa a2200169uu 4500 | ||
|---|---|---|---|
| 001 | 8012817514610 | ||
| 003 | OSt | ||
| 005 | 20190211163420.0 | ||
| 008 | 080128s2008 xx ||||gr |0|| 0 eng d | ||
| 100 | 1 |
_aMAOR, Moshe _96596 |
|
| 245 | 1 | 0 |
_aA Scientific standard and an agency's legal independence : _bwich of these reputation protection mechanisms is less susceptible to political moves? |
| 260 |
_aMalden, MA : _bBlackwell Publishers, _cDecember 2007 |
||
| 520 | 3 | _aThis article presents a model that introduces a scientific gold standard as a reputation protection mechanism operating alongside an agencys legal independence. It tries to gauge which of the two is less susceptible to political moves. The model suggests that the scientific gold standard for agency decisions is less susceptible to political moves because of its important role as a legitimating device for both government ministers and regulators. Government ministers are able to address multiple audiences and even to respond to aggressive strategies by powerful interest groups by undermining one reputation protection mechanism (that is, an agencys independence) without weakening the other (that is, the scientific barrier for granting full-subsidy status to treatments that lack comparative therapeutic advantage). This implies that drug reimbursement mechanisms that provide a high quality of drug evaluation are designed to be effective | |
| 773 | 0 | 8 |
_tPublic Administration : an international quarterly _g85, 4, p. 961-978 _dMalden, MA : Blackwell Publishers, December 2007 _xISSN 00333298 _w |
| 942 | _cS | ||
| 998 |
_a20080128 _b1751^b _cTiago |
||
| 999 |
_aConvertido do Formato PHL _bPHL2MARC21 1.1 _c25600 _d25600 |
||
| 041 | _aeng | ||